Middle artery embolization for chronic brain bleeding
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This study tests a procedure called middle meningeal artery embolization for people with a confirmed chronic subdural hematoma (a long-lasting bleed near the brain). It may help by reducing the blood supply to the area and improving symptoms after symptoms start or worsen.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a chronic subdural hematoma confirmed by a CT scan
- Your condition is being treated surgically because your symptoms are getting worse (new or worsening weakness, numbness, or other nerve problems)
- Your doctor feels you can safely have an angiography/contrast test (no serious contrast dye allergy)
- Your bleed is not caused by another structural problem (like an arachnoid cyst, certain blood vessel malformations, or you had cranial surgery in the past year)
- You (or your legal representative) can understand and sign consent, including if language barriers apply
- Your vision is not limited to only one eye because the other eye (on the opposite side) is blind
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with chronic subdural hematoma (a type of bleeding around the brain) who receive a procedure called middle meningeal artery embolization, which reduces blood flow to prevent rebleeding. Researchers will track your recovery with imaging and clinical assessments to understand how well this treatment works.
This trial tests a new technique during surgery for chronic subdural haematoma (bleeding between the brain and skull) where doctors use heat or special tools to seal a blood vessel (the middle meningeal artery) to help prevent the bleed from returning. The goal is to see if this addition to standard surgery is safe and feasible.
This study tests a new way to treat chronic subdural hematomas (a type of bleeding on the brain) by using a very thin tube to seal off a small artery inside the head. This may help the blood clot shrink without needing a traditional surgery.
This trial tests a procedure called middle meningeal artery embolization, which aims to stop the bleeding and reduce the fluid buildup from a chronic subdural hematoma. It may be an option for patients who have a hematoma at least 10mm thick and one or more risk factors such as older age, blood thinners, diabetes, or certain scan features.
This trial looks at how well a procedure called middle meningeal artery embolization works for people with chronic subdural hematoma (a collection of old blood on the brain's surface). It uses specific materials to block the blood supply to the hematoma, which may help the body reabsorb it without surgery.
This trial studies a procedure called middle-meningeal-artery embolization, which blocks the blood supply to a chronic subdural hematoma (a slow-growing blood collection around the brain). It compares outcomes in people with one-sided versus both-sided bleeds, and aims to see if this less invasive treatment can help reduce the need for surgery or improve recovery.
Hear when a new Chronic Subdural Hematomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.